Somatic inactivation or loss of the wild-type (WT) FLCN allele is observed in the renal tumours of patients with BHD disease and in sporadic renal cell carcinomas, suggesting that FLCN acts as a tumour suppressor9, 10. This evidence concerns the gene FLCN and kidney neoplasm.